CG
DXCM icon

Cutler Group’s DexCom DXCM Stock Holding History

Cutler Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1K Buy
+9,500
New +$1.19M ﹤0.01% 1987
2023
Q4 		– Sell
-600
Closed -$8K – 3767
2023
Q3 		$8K Sell
600
-1,200
-67% -$135K ﹤0.01% 2580
2023
Q2 		$6K Sell
1,800
-7,300
-80% -$883K ﹤0.01% 2521
2023
Q1 		$52K Sell
9,100
-16,300
-64% -$1.82M 0.01% 1325
2022
Q4 		$21K Buy
25,400
+15,300
+151% +$1.68M ﹤0.01% 2178
2022
Q3 		$166K Sell
10,100
-700
-6% -$59.3K 0.01% 1060
2022
Q2 		$323K Sell
10,800
-49,600
-82% -$4.53M 0.02% 723
2022
Q1 		$174K Buy
60,400
+56,400
+1,410% +$6.17M 0.01% 1289
2021
Q4 		$43K Sell
4,000
-17,600
-81% -$2.53M ﹤0.01% 2513
2021
Q3 		$93K Buy
+21,600
New +$2.72M ﹤0.01% 1970
2019
Q4 		– Sell
-15,200
Closed -$6K – 4105
2019
Q3 		$6K Buy
+15,200
New +$591K ﹤0.01% 2903
2018
Q4 		– Sell
-10,000
Closed -$3K – 4076
2018
Q3 		$3K Buy
+10,000
New +$310K ﹤0.01% 3303
2018
Q1 		– Sell
-4,000
Closed -$5K – 4618
2017
Q4 		$5K Sell
4,000
-26,400
-87% -$343K ﹤0.01% 3600
2017
Q3 		$28K Sell
30,400
-99,200
-77% -$1.75M ﹤0.01% 2794
2017
Q2 		$63K Sell
129,600
-32,000
-20% -$591K ﹤0.01% 2273
2017
Q1 		$75K Buy
161,600
+88,000
+120% +$1.72M ﹤0.01% 2017
2016
Q4 		$388K Buy
73,600
+48,000
+188% +$850K 0.01% 849
2016
Q3 		$21K Sell
25,600
-121,200
-83% -$2.7M ﹤0.01% 3365
2016
Q2 		$60K Sell
146,800
-158,800
-52% -$2.7M ﹤0.01% 2170
2016
Q1 		$134K Buy
305,600
+304,400
+25,367% +$5.09M 0.01% 1336
2015
Q4 		$1K Buy
+1,200
New +$25K ﹤0.01% 5890

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cutler Group's DXCM Position: Q1 2024 in Review

Cutler Group sold out of DexCom (DXCM) in Q1 2024, closing a stake of 455 shares — an estimated $57.2K sold.

Cutler Group first reported a position in DXCM in Q1 2016 and held it in 18 quarters. The position peaked at $1.42M in Q3 2021. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Cutler Group reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 455 DexCom shares in Q1 2024, an estimated $57.2K.
  • Cutler Group first reported a position in DexCom in Q1 2016 and held it in 18 quarters.
  • Cutler Group's DexCom position peaked at $1.42M in Q3 2021.
  • 1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.